Diabetes Clinical Trials in Denver

Showing 121-140 of 560 trials

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

NCT04476472

Subjects will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 94-day (13-week) hybrid closed-loop phase conducted in an outpatient setting, and an optional 12-month extension phase.

Type 1 Diabetes Mellitus

Insulet Corporation80 participantsStarted Sep 2020

Palo Alto, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +7 more locations

COMPLETEDPhase 48.4 miles

INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

NCT05904743

INHALE-3 is a Phase 4, randomized controlled trial (RCT) that will randomly assign participants ≥18 years of age with type 1 diabetes (T1D) using multiple daily injections (MDI), an automated insulin delivery (AID) system, or a pump without automation, and continuous glucose monitoring (CGM) 1:1 to an insulin regimen of insulin degludec plus inhaled insulin (Afrezza) and CGM or continuation of usual care. The primary outcome of the RCT is at 17 weeks. The RCT will be followed by a 13-week extension phase in which participants in both groups will use the degludec-inhaled insulin regimen.

Diabetes Mellitus, Type 1

Mannkind Corporation141 participantsStarted Jul 2023

Loma Linda, California, United States • Santa Barbara, California, United States • Aurora, Colorado, United States +16 more locations

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

Diabetes Trials in Other Cities

Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use

Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes

Depression in Youth Onset Type 2 Diabetes

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Preclinical Imaging Biomarkers of Alzheimer's Disease Neuropathology in Young Adults With Youth-onset Diabetes: a Proof-of-concept Study

Pregnancy Intervention With a Closed-Loop System (PICLS) Study

Dissemination of the Cardiovascular Risk Service

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy

The Effect of In-utero Exposure to Metformin in 5-11 Year Old Offspring of Mothers in the MiTy Trial

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

C-myc Biomarker Study for Diabetic Foot Ulcers

Other Conditions in Denver